U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 722

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr17:42455879
GRCh38:
Chr17:44378511
ITGA2BGlanzmann thrombastheniaPathogenic
(Aug 15, 2023)
reviewed by expert panel
FDA Recognized Database
2.
GRCh37:
Chr17:42462702-42462703
GRCh38:
Chr17:44385334-44385335
ITGA2BGlanzmann thrombastheniaPathogenic
(Sep 7, 2023)
reviewed by expert panel
FDA Recognized Database
3.
GRCh37:
Chr17:45384889-45384905
GRCh38:
Chr17:47307523-47307539
EFCAB13-DT, ITGB3Glanzmann thrombastheniaLikely pathogenic
(Aug 15, 2023)
reviewed by expert panel
FDA Recognized Database
4.
GRCh37:
Chr17:42457502-42457506
GRCh38:
Chr17:44380134-44380138
ITGA2BGlanzmann thrombastheniaUncertain significance
(Sep 7, 2023)
reviewed by expert panel
FDA Recognized Database
5.
GRCh37:
Chr17:45367068
GRCh38:
Chr17:47289702
ITGB3M321LGlanzmann thrombastheniaUncertain significance
(Sep 7, 2023)
reviewed by expert panel
FDA Recognized Database
6.
GRCh37:
Chr17:42461301
GRCh38:
Chr17:44383933
ITGA2BF320SGlanzmann thrombastheniaLikely pathogenic
(Aug 15, 2023)
reviewed by expert panel
FDA Recognized Database
7.
GRCh37:
Chr17:42457480
GRCh38:
Chr17:44380112
ITGA2BQ548*Glanzmann thrombastheniaPathogenic
(Jun 1, 2023)
reviewed by expert panel
FDA Recognized Database
8.
GRCh37:
Chr17:42462954
GRCh38:
Chr17:44385586
ITGA2BN180fsGlanzmann thrombastheniaPathogenic
(Jun 1, 2023)
reviewed by expert panel
FDA Recognized Database
9.
GRCh37:
Chr17:42463201
GRCh38:
Chr17:44385833
ITGA2B, LOC130060983D133EGlanzmann thrombastheniaPathogenic
(Jun 1, 2023)
reviewed by expert panel
FDA Recognized Database
10.
GRCh37:
Chr17:45385004
GRCh38:
Chr17:47307638
EFCAB13-DT, ITGB3Glanzmann thrombastheniaPathogenic
(Jun 1, 2023)
reviewed by expert panel
FDA Recognized Database
11.
GRCh37:
Chr17:42463476
GRCh38:
Chr17:44386108
ITGA2BP71RGlanzmann thrombastheniaLikely pathogenic
(Jun 1, 2023)
reviewed by expert panel
FDA Recognized Database
12.
GRCh37:
Chr17:45363657
GRCh38:
Chr17:47286291
ITGB3, LOC130061043Y216HGlanzmann thrombastheniaLikely pathogenic
(May 16, 2023)
reviewed by expert panel
FDA Recognized Database
13.
GRCh37:
Chr17:45380099
GRCh38:
Chr17:47302733
ITGB3K676TGlanzmann thrombastheniaUncertain significance
(May 16, 2023)
reviewed by expert panel
FDA Recognized Database
14.
GRCh37:
Chr17:45361920
GRCh38:
Chr17:47284554
ITGB3Q158LGlanzmann thrombastheniaUncertain significance
(May 16, 2023)
reviewed by expert panel
FDA Recognized Database
15.
GRCh37:
Chr17:42462661
GRCh38:
Chr17:44385293
ITGA2BV206DGlanzmann thrombastheniaUncertain significance
(May 16, 2023)
reviewed by expert panel
FDA Recognized Database
16.
GRCh37:
Chr17:42457765-42457774
GRCh38:
Chr17:44380397-44380406
ITGA2BQ508fsGlanzmann thrombastheniaPathogenic
(May 16, 2023)
reviewed by expert panel
FDA Recognized Database
17.
GRCh37:
Chr17:42457978
GRCh38:
Chr17:44380610
ITGA2BA477PGlanzmann thrombastheniaLikely pathogenic
(May 16, 2023)
reviewed by expert panel
FDA Recognized Database
18.
GRCh37:
Chr17:42453354
GRCh38:
Chr17:44375986
ITGA2BGlanzmann thrombastheniaPathogenic
(May 16, 2023)
reviewed by expert panel
FDA Recognized Database
19.
GRCh37:
Chr17:42456035
GRCh38:
Chr17:44378667
ITGA2BP641LGlanzmann thrombastheniaUncertain significance
(May 16, 2023)
reviewed by expert panel
FDA Recognized Database
20.
GRCh37:
Chr17:42453323-42453324
GRCh38:
Chr17:44375955-44375956
ITGA2BG827fsGlanzmann thrombastheniaLikely pathogenic
(May 16, 2023)
reviewed by expert panel
FDA Recognized Database
21.
GRCh37:
Chr17:45362046
GRCh38:
Chr17:47284680
ITGB3N201fsGlanzmann thrombastheniaPathogenic
(Jan 17, 2023)
reviewed by expert panel
FDA Recognized Database
22.
GRCh37:
Chr17:45369900-45369902
GRCh38:
Chr17:47292534-47292536
ITGB3S553delGlanzmann thrombastheniaUncertain significance
(Apr 6, 2023)
reviewed by expert panel
FDA Recognized Database
23.
GRCh37:
Chr17:45351860
GRCh38:
Chr17:47274494
ITGB3C52FGlanzmann thrombastheniaUncertain significance
(Apr 6, 2023)
reviewed by expert panel
FDA Recognized Database
24.
GRCh37:
Chr17:45361985
GRCh38:
Chr17:47284619
ITGB3G180RGlanzmann thrombastheniaUncertain significance
(Apr 6, 2023)
reviewed by expert panel
FDA Recognized Database
25.
GRCh37:
Chr17:45331229
GRCh38:
Chr17:47253863
ITGB3, LOC130061041M1TGlanzmann thrombastheniaUncertain significance
(Apr 6, 2023)
reviewed by expert panel
FDA Recognized Database
26.
GRCh37:
Chr17:45364542-45364556
GRCh38:
Chr17:47287176-47287190
ITGB3Glanzmann thrombastheniaLikely pathogenic
(Apr 6, 2023)
reviewed by expert panel
FDA Recognized Database
27.
GRCh37:
Chr17:42462973
GRCh38:
Chr17:44385605
ITGA2BY174HGlanzmann thrombastheniaLikely pathogenic
(Apr 6, 2023)
reviewed by expert panel
FDA Recognized Database
28.
GRCh37:
Chr17:42452037
GRCh38:
Chr17:44374669
ITGA2BG978VGlanzmann thrombastheniaUncertain significance
(Apr 6, 2023)
reviewed by expert panel
FDA Recognized Database
29.
GRCh37:
Chr17:42451788
GRCh38:
Chr17:44374420
ITGA2BW998*Glanzmann thrombastheniaPathogenic
(Apr 7, 2023)
reviewed by expert panel
FDA Recognized Database
30.
GRCh37:
Chr17:45377920
GRCh38:
Chr17:47300554
ITGB3E664*Glanzmann thrombastheniaPathogenic
(Jan 17, 2023)
reviewed by expert panel
FDA Recognized Database
31.
GRCh37:
Chr17:45361832
GRCh38:
Chr17:47284466
ITGB3Q129KGlanzmann thrombastheniaUncertain significance
(Mar 21, 2023)
reviewed by expert panel
FDA Recognized Database
32.
GRCh37:
Chr17:45364468-45364469
GRCh38:
Chr17:47287102-47287103
ITGB3, LOC130061045L271fsGlanzmann thrombastheniaPathogenic
(Mar 21, 2023)
reviewed by expert panel
FDA Recognized Database
33.
GRCh37:
Chr17:45361934
GRCh38:
Chr17:47284568
ITGB3K163QGlanzmann thrombastheniaUncertain significance
(Mar 21, 2023)
reviewed by expert panel
FDA Recognized Database
34.
GRCh37:
Chr17:42456008
GRCh38:
Chr17:44378640
ITGA2BGlanzmann thrombastheniaLikely pathogenic
(Mar 21, 2023)
reviewed by expert panel
FDA Recognized Database
35.
GRCh37:
Chr17:42453485-42453486
GRCh38:
Chr17:44376117-44376118
ITGA2BD805fsGlanzmann thrombastheniaPathogenic
(Jan 17, 2023)
reviewed by expert panel
FDA Recognized Database
36.
GRCh37:
Chr17:42457661
GRCh38:
Chr17:44380293
ITGA2BI518NGlanzmann thrombastheniaLikely pathogenic
(Mar 21, 2023)
reviewed by expert panel
FDA Recognized Database
37.
GRCh37:
Chr17:42454380
GRCh38:
Chr17:44377012
ITGA2BR755QGlanzmann thrombastheniaUncertain significance
(Mar 21, 2023)
reviewed by expert panel
FDA Recognized Database
38.
GRCh37:
Chr17:45364450
GRCh38:
Chr17:47287084
ITGB3W264*Glanzmann thrombastheniaPathogenic
(Feb 2, 2023)
reviewed by expert panel
FDA Recognized Database
39.
GRCh37:
Chr17:42453709
GRCh38:
Chr17:44376341
ITGA2BP772RGlanzmann thrombastheniaUncertain significance
(Jan 17, 2023)
reviewed by expert panel
FDA Recognized Database
40.
GRCh37:
Chr17:42463023
GRCh38:
Chr17:44385655
ITGA2BP157HGlanzmann thrombastheniaPathogenic
(Feb 2, 2023)
reviewed by expert panel
FDA Recognized Database
41.
GRCh37:
Chr17:45369859-45369860
GRCh38:
Chr17:47292493-47292494
ITGB3F539fsGlanzmann thrombastheniaPathogenic
(Feb 2, 2023)
reviewed by expert panel
FDA Recognized Database
42.
GRCh37:
Chr17:42466667
GRCh38:
Chr17:44389299
ITGA2BD59fsGlanzmann thrombastheniaPathogenic
(Feb 23, 2023)
reviewed by expert panel
FDA Recognized Database
43.
GRCh37:
Chr17:45376801
GRCh38:
Chr17:47299435
ITGB3K606NGlanzmann thrombastheniaUncertain significance
(Feb 2, 2023)
reviewed by expert panel
FDA Recognized Database
44.
GRCh37:
Chr17:45369720
GRCh38:
Chr17:47292354
ITGB3W492*Glanzmann thrombastheniaPathogenic
(Jan 17, 2023)
reviewed by expert panel
FDA Recognized Database
45.
GRCh37:
Chr17:42452029
GRCh38:
Chr17:44374661
ITGA2BQ981*Glanzmann thrombastheniaPathogenic
(Jan 17, 2023)
reviewed by expert panel
FDA Recognized Database
46.
GRCh37:
Chr17:45363666
GRCh38:
Chr17:47286300
ITGB3, LOC130061043V219MGlanzmann thrombastheniaLikely pathogenic
(Jan 17, 2023)
reviewed by expert panel
FDA Recognized Database
47.
GRCh37:
Chr17:42463377
GRCh38:
Chr17:44386009
ITGA2BGlanzmann thrombastheniaPathogenic
(Jan 17, 2023)
reviewed by expert panel
FDA Recognized Database
48.
GRCh37:
Chr17:42457656
GRCh38:
Chr17:44380288
ITGA2BM520LGlanzmann thrombastheniaUncertain significance
(Oct 7, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr17:42453240
GRCh38:
Chr17:44375872
ITGA2BGlanzmann thrombastheniaLikely benign
(Mar 21, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr17:42460875
GRCh38:
Chr17:44383507
ITGA2BR399Qnot provided, Glanzmann thrombastheniaUncertain significance
(Dec 19, 2022)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr17:42455791
GRCh38:
Chr17:44378423
ITGA2BA678VGlanzmann thrombastheniaUncertain significance
(Sep 13, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr17:42462296
GRCh38:
Chr17:44384928
ITGA2BGlanzmann thrombastheniaLikely benign
(Aug 10, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr17:42460961
GRCh38:
Chr17:44383593
ITGA2BGlanzmann thrombastheniaLikely benign
(May 25, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr17:42461949
GRCh38:
Chr17:44384581
ITGA2BGlanzmann thrombastheniaLikely benign
(Aug 28, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr17:42458342
GRCh38:
Chr17:44380974
ITGA2BR433HGlanzmann thrombastheniaUncertain significance
(Aug 5, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr17:42453436
GRCh38:
Chr17:44376068
ITGA2BGlanzmann thrombastheniaLikely benign
(Jun 15, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr17:42453040
GRCh38:
Chr17:44375672
ITGA2BGlanzmann thrombastheniaLikely benign
(Aug 19, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr17:42452440
GRCh38:
Chr17:44375072
ITGA2BL923VGlanzmann thrombastheniaUncertain significance
(Mar 13, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr17:42463506
GRCh38:
Chr17:44386138
ITGA2BGlanzmann thrombastheniaLikely benign
(Sep 30, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr17:42461681
GRCh38:
Chr17:44384313
ITGA2BA297TGlanzmann thrombastheniaUncertain significance
(Sep 3, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr17:42449796
GRCh38:
Chr17:44372428
ITGA2BGlanzmann thrombastheniaLikely benign
(May 11, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr17:45361920
GRCh38:
Chr17:47284554
ITGB3Q158RGlanzmann thrombastheniaUncertain significance
(Jun 1, 2023)
reviewed by expert panel
FDA Recognized Database
63.
GRCh37:
Chr17:42462679
GRCh38:
Chr17:44385311
ITGA2BA200VGlanzmann thrombastheniaUncertain significance
(Oct 25, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr17:42453026
GRCh38:
Chr17:44375658
ITGA2BR887QGlanzmann thrombasthenia, Inborn genetic diseasesUncertain significance
(Jun 9, 2022)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr17:42449769
GRCh38:
Chr17:44372401
ITGA2BR1028QGlanzmann thrombastheniaUncertain significance
(Jul 20, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr17:42453449
GRCh38:
Chr17:44376081
ITGA2BGlanzmann thrombastheniaUncertain significance
(Aug 28, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr17:42457474
GRCh38:
Chr17:44380106
ITGA2BGlanzmann thrombastheniaLikely benign
(Sep 5, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr17:42457393
GRCh38:
Chr17:44380025
ITGA2BH577NGlanzmann thrombastheniaUncertain significance
(Sep 5, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr17:42457371
GRCh38:
Chr17:44380003
ITGA2BR584QGlanzmann thrombastheniaUncertain significance
(Aug 22, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr17:42449804
GRCh38:
Chr17:44372436
ITGA2BGlanzmann thrombastheniaLikely benign
(Oct 17, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr17:42453234
GRCh38:
Chr17:44375866
ITGA2BQ856HGlanzmann thrombastheniaUncertain significance
(Jun 3, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr17:42463440
GRCh38:
Chr17:44386072
ITGA2BG83DInborn genetic diseases, Glanzmann thrombastheniaUncertain significance
(Dec 13, 2022)
criteria provided, multiple submitters, no conflicts
73.
GRCh37:
Chr17:42453322
GRCh38:
Chr17:44375954
ITGA2BG827VGlanzmann thrombastheniaUncertain significance
(Feb 14, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr17:42462385
GRCh38:
Chr17:44385017
ITGA2BGlanzmann thrombastheniaLikely benign
(Oct 4, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr17:42461254
GRCh38:
Chr17:44383886
ITGA2BGlanzmann thrombastheniaLikely benign
(Mar 18, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr17:42463489
GRCh38:
Chr17:44386121
ITGA2BV67MGlanzmann thrombastheniaUncertain significance
(Jun 8, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr17:42452435
GRCh38:
Chr17:44375067
ITGA2BGlanzmann thrombastheniaLikely benign
(Jun 23, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr17:42453765
GRCh38:
Chr17:44376397
ITGA2BGlanzmann thrombastheniaUncertain significance
(Mar 21, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr17:42455060
GRCh38:
Chr17:44377692
ITGA2BGlanzmann thrombastheniaUncertain significance
(Aug 19, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr17:42456086
GRCh38:
Chr17:44378718
ITGA2BGlanzmann thrombastheniaLikely benign
(Jul 27, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr17:42452961
GRCh38:
Chr17:44375593
ITGA2BV909LGlanzmann thrombastheniaUncertain significance
(Jun 14, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr17:42455805
GRCh38:
Chr17:44378437
ITGA2BE673DInborn genetic diseases, Glanzmann thrombastheniaUncertain significance
(Oct 12, 2022)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr17:42456013
GRCh38:
Chr17:44378645
ITGA2BGlanzmann thrombastheniaUncertain significance
(Jul 19, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr17:42458256
GRCh38:
Chr17:44380888
ITGA2BG462RGlanzmann thrombastheniaUncertain significance
(Sep 27, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr17:42456009
GRCh38:
Chr17:44378641
ITGA2BGlanzmann thrombastheniaLikely pathogenic
(May 13, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr17:42461457
GRCh38:
Chr17:44384089
ITGA2BE314GGlanzmann thrombastheniaUncertain significance
(May 4, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr17:42452499
GRCh38:
Chr17:44375131
ITGA2BGlanzmann thrombastheniaLikely benign
(Aug 12, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr17:42453227
GRCh38:
Chr17:44375859
ITGA2BP859SGlanzmann thrombastheniaUncertain significance
(Mar 4, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr17:42452466
GRCh38:
Chr17:44375098
ITGA2BA914EGlanzmann thrombastheniaUncertain significance
(Feb 8, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr17:42455808
GRCh38:
Chr17:44378440
ITGA2BGlanzmann thrombastheniaLikely benign
(Aug 27, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr17:42453659
GRCh38:
Chr17:44376291
ITGA2BGlanzmann thrombastheniaLikely benign
(Sep 14, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr17:42458369
GRCh38:
Chr17:44381001
ITGA2BL424RGlanzmann thrombastheniaUncertain significance
(Jan 11, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr17:42461526
GRCh38:
Chr17:44384158
ITGA2BGlanzmann thrombastheniaLikely benign
(Oct 24, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr17:42457985
GRCh38:
Chr17:44380617
ITGA2BGlanzmann thrombastheniaLikely benign
(Jul 14, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr17:42453703
GRCh38:
Chr17:44376335
ITGA2BR774QGlanzmann thrombastheniaUncertain significance
(Sep 13, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr17:42452009
GRCh38:
Chr17:44374641
ITGA2Bnot specified, Glanzmann thrombastheniaBenign/Likely benign
(Sep 6, 2023)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr17:42461247
GRCh38:
Chr17:44383879
ITGA2BGlanzmann thrombastheniaLikely benign
(Mar 1, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr17:42461282
GRCh38:
Chr17:44383914
ITGA2BGlanzmann thrombastheniaLikely benign
(Jun 12, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr17:42452355-42452356
GRCh38:
Chr17:44374987-44374988
ITGA2BGlanzmann thrombastheniaUncertain significance
(Feb 11, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr17:42455747
GRCh38:
Chr17:44378379
ITGA2BA693TGlanzmann thrombastheniaUncertain significance
(Sep 27, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination